The world cancer-treating drugs market is expected to grow at a CAGR of 6.6% in the second half of the forecast period 2017-2027

Thursday, November 9, 2017 Drug News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, Nov. 8, 2017 /PRNewswire/ -- Immunotherapy, Chemotherapy, Targeted Therapy, Hormone Therapy, Leading DrugsReport Details

Download the full report: world cancer-treating drugs market is expected to grow at a CAGR of 6.6% in the second half of the forecast period. The market reached $102bn
in 2016, dominated by the immunotherapy segment which held 44.1% share of the market.How this report will benefit youRead on to discover how you can exploit the future business opportunities emerging in this sector.In this brand new 194-page report you will receive 110 tables and 101 figures – all unavailable elsewhere.The 194-page report provides clear detailed insight into the world cancer-treating drugs market. Discover the key drivers and challenges affecting the market.By ordering and reading our brand-new report today you stay better informed and ready to act.Report Scope• World cancer-treating drugs market forecasts from 2017-2027This report also breaks down the revenue forecast for the world cancer-treating drugs market by its leading segments:- Immunotherapy- Chemotherapy- Targeted Therapy- Hormone TherapyEach sector is analysed and revenue forecasts presented.This report discusses and forecasts revenues of the top 25 anti-cancer drugs:- Avastin- Herceptin- Rituxan- Gleevec- Revlimid- Alimta- Velcade- Erbitux- Gardasil- Zytiga- Xeloda- Tarceva- Afinitor- Sprycel- Tasigna- Sutent- Nexavar- Xgeva- Zoladex- Yervoy- Vidaza- Treanda- Temodar- Faslodex- Abraxane- OthersThis report provides individual revenue forecasts to 2027 for these regional and national markets:- North America: US, Canada, Mexico- South America: Brazil, Argentina, Paraguay, Brazil, Rest of South America- Europe: The UK, Germany, France, Spain, Italy, Rest of Europe- Asia-Pacific: China, Japan, India, Australia, Thailand, Rest of Asia-Pacific- Rest of World: Middle East, Africa, Other Countries• This report discusses trends in the industry and assesses strengths and weaknesses, as well as opportunities and threats (SWOT). It also analyses social, technological, economic and political factors (STEP) that influence the cancer-treating drugs marketOur study discusses the selected leading companies that are the major players in the cancer-treating drugs market:- AstraZeneca- Merck & Co., Inc. (Merck)- Novartis- Amgen- Bristol-Myers Squibb (BMS)- GlaxoSmithKline (GSK)- Johnson & Johnson (J&J)- Roche- Eli Lilly- CelgeneThe report provides overviews of the companies, financial information, product portfolio, pipeline products and recent developments.Visiongain's study is intended for anyone requiring commercial analyses for the world cancer-treating drugs market. You find data, trends and predictions.Buy our report today World Cancer-Treating Drugs Market Forecast 2017-2027: Immunotherapy, Chemotherapy, Targeted Therapy, Hormone Therapy, Leading Drugs.Download the full report: About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith Research Advisor at Email: Tel: +44 208 816 85 48 Website:


View original content:

SOURCE ReportBuyer

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store